a review of the management of gallstone disease and its

Upload: lina-e-arango

Post on 20-Feb-2018

218 views

Category:

Documents


0 download

TRANSCRIPT

  • 7/24/2019 A Review of the Management of Gallstone Disease and Its

    1/10

    Review

    A review of the management of gallstone disease and its

    complications in pregnancy

    R.S. Date, M.D., F.R.C.S.a,*, M. Kaushal, F.R.C.S.b, A. Ramesh, F.R.C.S.c

    aDepartment of Gastrointestinal Surgery, Lancashire Teaching Hospital NHS Foundation Trust; bDepartment of

    Gastrointestinal Surgery, Royal Blackburn Hospital; cDepartment of Gastrointestinal Surgery,

    South Manchester University Hospital

    Abstract

    BACKGROUND: Symptomatic gallstone disease is the second most common abdominal emergency in

    pregnant women. There have been significant developments in the management of gallstone disease, but risk

    to the fetus has prevented their routine application in pregnant women. We reviewed the literature to find the

    current best evidence for the management of gallstones and its complications in pregnancy.

    DATA SOURCES: MEDLINE and PubMed literature searches were performed to identify original

    studies.

    RESULTS AND CONCLUSIONS: Six studies comparing conservative with surgical management of cho-

    lecystitis showed no significant difference in incidence of preterm delivery (3.5% vs 6.0%,P .33) or fetal

    mortality (2.2% vs 1.2%, P .57). There was no maternal or fetal mortality in 20 reports of laparoscopic

    cholecystectomy and 9 reports of endoscopic retrograde cholangiopancreatography, thus indicating their

    safety when performed with necessary precautions. Laparoscopic cholecystectomy is a safe procedure in all

    trimesters. In 12 reports of gallstone pancreatitis, fetal mortality was 8.0% versus 2.6% (P .28) in

    conservative and surgical groups, respectively, suggesting the need for earlier surgical intervention.

    2008 Elsevier Inc. All rights reserved.

    KEYWORDS:Cholecystectomy;

    Cholecystitis;

    Endoscopic retrograde

    cholangiopancreatography;

    Gall bladder;

    Pregnancy;

    Pancreatitis

    The most common abdominal emergencies during preg-

    nancy are cholecystitis, acute appendicitis, and intestinal

    obstruction.1,2 The incidence of gallstone-related diseases

    complicating pregnancy is .05 to .8%36, and management

    of these diseases has always been a difficult diagnostic and

    therapeutic challenge to surgeons.

    The current literature recommends surgical rather than

    conservative treatment of acute cholecystitis, within 72

    hours of presentation in nonpregnant patients.7,8 The British

    Society of Gastroenterology guidelines recommend chole-

    cystectomy within 2 weeks of index admission for gallstone

    pancreatitis.9 However, the potential risk of fetal death from

    both disease and cholecystectomy make these decisions

    difficult in pregnant patients.

    Other perceived anxieties during pregnancy are risk of ra-

    diation to the fetus during endoscopic retrograde cholangio-

    pancreatography (ERCP), mechanical and physiologic effectsof laparoscopic cholecystectomy (LC) and the risk of anaes-

    thesia, and the effects of magnetic fields on the fetus during

    magnetic resonance cholangiopancreatography (MRCP).

    Most literature on this subject is in the form of anecdotal

    reports. Reviews supporting the feasibility and safety of LC

    were published toward the end of the 20th century,10,11 but

    they did not provide any firm guidance on the management of

    gall bladder disease in general. There have been sporadic

    reports of MRCP in pregnancy.12,13 There have not been any

    reviews on ERCP or the management of gallstone pancreatitis.

    * Corresponding author. Tel.: 011-01257 245 267; fax: 011-01257

    245 495.

    E-mail address:[email protected]

    Manuscript received December 19, 2007; revised manuscript January

    19, 2008

    0002-9610/$ - see front matter 2008 Elsevier Inc. All rights reserved.

    doi:10.1016/j.amjsurg.2008.01.015

    The American Journal of Surgery (2008) 196, 599608

    mailto:[email protected]:[email protected]:[email protected]
  • 7/24/2019 A Review of the Management of Gallstone Disease and Its

    2/10

    Absence of reliable guidelines on this subject prompted

    us to review the literature to find the current best evidence

    for the comprehensive management of biliary disease in

    pregnant women.

    Methods

    Literature search

    A computerized search was made of the PubMed and

    MEDLINE databases for the period from January 1966

    through October 2007. The Ovid search engine (version 9;

    Ovid Technologies, New York, New York) was employed.

    The MESH headings cholecystitis, cholecystectomy,

    obstructive jaundice, choledocholithiasis, endoscopic

    retrograde cholangiopancreatography, magnetic resonance

    cholangiopancreatography, and pancreatitis were searched.These searches were combined using the term OR. Then

    Medline Subject Heading pregnancy was searched. The 2

    searches were then combined using the term and (Fig. 1).

    Abstracts of the articles found were scrutinized to iden-

    tify the original human studies and also to exclude editori-

    als, review articles, and letters. The full text of each of the

    human studies was obtained and studied. Manual cross-

    referencing was then carried out, based on the bibliography

    of articles identified in the original searches, to ensure

    inclusion of all possible studies. Articles were excluded if

    they were duplicate studies on the same patient group.

    The literature was considered under the following head-

    ings (some overlap is inevitable because of the wide spec-

    trum of presentation of gallstones):

    1. Management of symptomatic cholelithiasis: surgical ver-

    sus conservative management

    2. Management of choledocholithiasis: MRCP, ERCP, in-

    traoperative cholangiogram (IOC), and common bile

    duct (CBD) exploration

    3. Management of acute pancreatitis (AP)

    4. Surgery for gallstone disease (comparison of open versus

    laparoscopic cholecystectomy, LC)

    Statistical analyses

    Throughout the report, n refers to the number of patients.

    Statistical analyses were carried out using the SPSS software

    package (version 11.5; SPSS, Chicago IL). Pearsons chi-square test was used to compare proportions in the 2 groups.

    Results

    Management of symptomatic cholelithiasis

    The literature on cholelithiasis and pregnancy is broadly

    divided into the prelaparoscopic cholecystectomy era and

    Figure 1 Summary of literature search.

    600 The American Journal of Surgery, Vol 196, No 4, October 2008

  • 7/24/2019 A Review of the Management of Gallstone Disease and Its

    3/10

    the post-LC era. The 3 original reports published just before

    the laparoscopic era can be considered representative of

    practice at the time1416 (Table 1). Two of these case stud-

    ies, published from Los Angeles, held different views. In a

    review of 44 patients, Dixon et al14 recommended surgical

    treatment for patients presenting with biliary symptoms

    during the second trimester of pregnancy, or even before the

    planned pregnancy, if symptomatic gallstones were diag-nosed in young women. They also recommended a conser-

    vative approach during the first and third trimesters of

    pregnancy. In contrast, continuation of medical manage-

    ment until delivery was recommended in a review of 26

    patients by Hiatt et al15 because there was high fetal mor-

    tality in the surgical group. The investigators stated, how-

    ever, that should surgery become necessary, it should be

    done during the second trimester. Another study of 9 pa-

    tients published at approximately thesame time reported

    high fetal loss (5 of 9 pregnancies).16 These articles high-

    light some interesting facts regarding medical practice in

    that era. Five of 46 (11%) patients in these 3 studies werefound to have unsuspected pregnancy after undergoing cho-

    lecystectomy. Three of 7 patients presenting with biliary

    symptoms during the first trimester requested therapeutic

    abortion because they had been exposed to radiation during

    the investigation.16 Because there were significant changes

    in medical practice when these studies were performed and

    reports written, the prelaparoscopic literature should be

    viewed with caution. The safety of surgical intervention

    during the second trimester, however, is reflected even in

    the prelaparoscopic literature.

    Conservative versus surgical treatment

    There were 6 reports of 310 patients comparing conser-

    vative with surgical management.2,11,1720(Table 2) All of

    the patients were initially treated conservatively. No mater-

    nal mortality was reported in either group.

    In patients treated conservatively, readmission rate was

    38% to 70%.19,20 Swisher et al20 reported an average of 2 to

    6 relapses during pregnancy; Elamin et al17 reported an

    average of 4 1.3 admissions for relapse; and Lu et al17

    reported 1 to 3 additional admissions, each lasting 5 to 8

    days.19

    Each subsequent relapse was more severe than theprevious one.19

    Eighty-three (27%) patients had to undergo surgery due

    to the failure of conservative treatment (Table 2). Glasgow

    et al reported an increasing trend toward surgical manage-

    ment after the introduction of LC.18 In this series, 2 of 15

    (13%) patients were offered surgery from 1980 through

    1990, compared with 15 of 32 (47%) patients from 1991

    through 1996, because conservative treatment failed.

    The incidence of preterm deliveries with conservative

    management was 8 of 227 (3.5%) patients compared with 5

    of 83 (6.0%) patients receiving surgical treatment (P .33).

    Similar figures for fetal mortality were 5 of 227 (2.2%) and1 of 83 (1.2%), respectively (P .57).

    Tab

    le

    1

    Gallstonediseaseand

    pregnanc

    yin

    theprelaparoscopicera

    Inv

    estigators

    Patients

    (totaln)

    Conservativemanagement

    Surgicalmanagement

    Patients(n)

    Premature

    deliveries(n)

    Fetalmortality

    (trimester1/2/3)

    Patients(n)

    Indication

    BC/AC/GSP

    Tim

    eofsurgery

    (tr

    imesters1

    through

    3)

    Premature

    deliveries(n)

    Fetalmortality

    (trimester1/2/3)

    Hia

    ttetal.15

    26

    7

    0

    0

    19

    4/5/?

    5/2/2*

    0

    5/1/0

    Dix

    on

    etal.14

    44

    26

    2

    5/1/0

    18

    NA

    3/14/1

    1

    3/0/0

    Lan

    dersetal.16

    30

    21

    NA

    NA

    9

    NA

    4/3/2

    2

    3/0/1

    AC

    acutecholecystitis;BC

    biliarycolic

    ;GSP

    gallstonepancreatitis.

    *Ten

    patientswerepostpartum.

    601R.S. Date et al. Review of gallstone disease management

  • 7/24/2019 A Review of the Management of Gallstone Disease and Its

    4/10

    The study by Elamin et al17 stands out from the others

    because of the high frequency (.33%) of acute cholecystitis

    during pregnancy. This was thought to be caused by the

    high prevalence of gallstones, early marriage, and repeat

    pregnancies in the community. The investigators also re-

    ported a high incidence of preterm delivery (n 9), abor-

    tion (n 5), and fetal deaths (n 2) in their study of 49

    patients.Apart from this report, there were 2 preterm deliveries

    each in the surgical and conservative groups. Both preterm

    deliveries in the surgical group appeared to be unrelated to

    surgery. One patient had twins who were delivered in week

    30 (20 weeks after LC),20 and the other patient delivered in

    week 35 (25 weeks after LC).18 The only fetal death apart

    from that in Elamins study was reported by Lu et al,19 and

    this was not related to gallstone disease.

    Management of choledocholithiasis

    Ductal stones may pose a risk to both fetus and mother

    by causing obstructive jaundice, cholangitis, or pancreatitis.

    There is also the risk of exposure to ionizing radiation and

    to magnetic fields during ERCP, IOC, and MRCP.

    Until recently, ERCP was contraindicated in pregnancy.

    It was thought that ionizing radiation would cause birth

    defects or even loss of the fetus. Since the early 1990s, there

    have been 9 reports on ERCP in pregnancy, all of which

    showed that there is no serious harm to mother or fetus

    (Table 3). The amount of radiation used during ERCP was

    18 to 310 mrad,2123 which is lower than the harmful dose

    of 5 to 10 rad, which is the dose at which fetal damage isknown to occur. Radiation risk is greatest during the first

    trimester. Some endoscopists have reported undertaking

    ERCP without fluoroscopy in pregnant women to minimize

    radiation risk.24,25

    The other main risk during ERCP is maternal pancreati-

    tis. The cumulative incidence of pancreatitis in these studies

    was 5 of 104 (4.8%).22,23,2628 All cases of pancreatitis were

    mild and self-limiting. Other complications noted were

    bleeding (n 2) and pre-eclampsia (n 2).

    There were 4 published case reports ofMRCP in preg-

    nant women for stones and cancer.12,13,29,30 No maternal or

    fetal morbidity or mortality was noted in these reports. IOCwith LC was described in 8 reports.6,19,3136 IOC was used

    frequently, along with cholecystectomy, until the early

    1990s. However, recent literature recommends the use of

    IOC only in the presence of choledocholithiasis and during

    exploration of CBD.33 Morrell et al and Cosenza et al

    recommended use of a shield to cover the fetus.31,34 Glas-

    gow et al18 did not use IOC but described the use of

    laparoscopic ultrasound (US) scan in 6 patients to exclude

    retained CBD stones.18 From these reports, it is clear that

    there was no maternal morbidity or mortality. However, 1

    spontaneous abortion was reported.32

    Six cases of laparoscopic13,18,3739 and 20 cases ofopen6,19,20,31,40 CBD exploration were described in the

    Tab

    le

    2

    Trialofconservativeversussurgicaltreatment

    Inv

    estigators

    Patients

    (totaln)

    Conservat

    ivemanagement

    Surgicalmanagement

    Patients(

    n)

    Premature

    deliveries(n)

    Fetalmortality

    (trimester1/2/3)

    No.of

    patients

    Indication

    BC/AC/GSP

    Timeofsurgery

    (trimester1/2/3)

    Premature

    deliveries(n)

    Fetalmortality

    (trimester1/2/3)

    Gla

    sgow

    18

    47

    30

    0

    0

    17

    10/6/1

    3/13/1a

    1

    0

    Elamin17

    49

    34

    6

    0/0/4

    15

    0/15/0

    NA

    3

    0/0/1

    Dar

    adkeh2

    42

    26

    0

    0

    16

    13/3/0

    2/10/4

    0

    0

    Swisher2

    0

    72

    56

    0

    0

    16

    3/4/4b

    5/11/0

    1

    0

    Sun

    gler11

    37

    28

    0

    0

    9

    5/2/2

    0/8/1

    0

    0

    Lu19

    63

    53

    2

    0/1/0d

    10

    NA/NA/2c

    0/8/2

    0

    0

    Tot

    al

    310

    227

    8

    5

    83

    31/38/9

    10/50/8

    5

    1

    aLaparoscopic

    3/11/0;open

    0/2/1.

    bno

    dataavailableforindication

    in

    5

    patients.

    cindicationsforsurgerywererefractorypain

    ,deteriorating

    clinicalstatus,orpresentati

    on

    during

    thesecond

    trimester.

    dtwin

    pregnancy;death

    from

    unknown

    etiol

    ogy.

    602 The American Journal of Surgery, Vol 196, No 4, October 2008

  • 7/24/2019 A Review of the Management of Gallstone Disease and Its

    5/10

    literature. There was no maternal or fetal morbidity or

    mortality.

    Management of gallstone pancreatitisduring pregnancy

    AP in pregnancy has attracted attention since the early

    part of the 20th century, suggesting a specific association

    between the 2 conditions.41

    In 1973, Wilkinson42

    reviewed98 cases of AP during pregnancy and reported a further 8

    new cases. In these 98 cases, maternal outcome was re-

    corded in 81 women, of whom 30 (37%) died. This mor-

    tality rate is much higher than that associated with pancre-

    atitis in the modern era (10%).9 A total of 12 case studies

    has been published since then (including this report) report-

    ing a total of 212 patients. Forty-one patients had AP during

    the postpartum period. Of the remaining 171 patients, 113

    had confirmed gallstone-induced AP (Table 4). For the

    purpose of this review, we analyzed this group of 113 cases.

    Seventy five (66.3%) patients were managed conserva-

    tively, and 38 (33.7%) underwent surgery (Table 5). Twopatients underwent drainage of pancreatic abscess, and the

    remainder underwent cholecystectomy. The indication for

    cholecystectomy was failure to respond to conservative

    management or recurrent disease in 21 (55.2%) patients,

    and 15 (39.5%) patients underwent planned surgery to pre-

    vent recurrence. One patient underwent cholecystectomy

    and CBD exploration for a presentation of gallstone pan-

    creatitis (GSP) and obstructive jaundice.19 There was no

    maternal mortality in either the surgical group or the con-

    servatively treated group.

    Morbidity in surgical group included prolonged paren-

    teral nutrition in 1 patient because of intolerance to oralfluids after LC19 and splenic hematoma in 1 patient, who

    was treated conservatively.43 There were 6 premature de-

    liveries in these studies, including 3 low birthweight ba-

    bies. Overall fetal mortality was 8 (7.07%): 6 in the con-

    servatively managed group and 2 in the surgical group (P

    .28). Two patients lost fetuses: 1 after LC and the other after

    drainage of pancreatic abscess.44

    Surgery for gallstone disease

    LC.In the early days, pregnancy was considered to be an

    absolute contraindication for LC. Subsequently, many case

    reports were published testifying to the feasibility and safety

    of the procedure during pregnancy. These reports were

    reviewed independently by Ghumman et al, Nezhat et al,

    and Sungler et al, in the late 1990s.10,11,45 The investigators

    concluded that LC was a safe and effective option for

    Table 3 ERCP during pregnancy

    Investigators

    Patients

    (n)

    ERCP

    (n)

    ECRP timing

    (trimester

    1/2/3)

    Indication

    C/GSP/OJ/other EBS

    Maternal

    morbidity (n)

    Fetal

    morbidity (n)

    Fetal

    mortality

    Average

    radiation

    dose (mrad)

    Jamidar28 23 29 15/8/6 0/1/18/4 15# 1 pancreatitis 1^ 2 NAFarca21 10 11 3/5/2 0/2/0/8 1 0 0 0 18

    Barthel26

    3 3 NA 3 1 pancreatitis 0 0 NASungler11 5 5 0/4/1 0/2/3/0 5 0 0 0Howden63 21 22 5/11/6 0/7/6/8 17 N/A 1^ 0 205Tham23 15 15 1/5/9 0/6/2/7 6# 1 pancreatitis 0 0 310Simmons25 6 6 3/1/2 5/1/0/0 6 0 1 1 0Kahaleh22 17 17 4/9/4 2/10/0/5 17 1 bleeding

    1 pancreatitis

    2 pre-eclampsia

    2^ 0 40

    Gupta27 18 18 4/6/8 3/1/0/14 17 1 pancreatitis

    1 bleeding

    1^ 0 NA

    Total 118 126 35/49/38 10/30/29/46 87 6 3

    C cholangitis; EBS endoscopic biliary sphincterotomy; OJ obstructive jaundice.

    #Biliary stent inserted in 1 patient.

    ^preterm delivery.

    one infant death, 1 abortion, and 2 additional elective abortions.

    Table 4 GSP during pregnancy

    Investigators AP (total n)AP duringpregnancy (n) GSP (n)

    Corlett64 52 43 12Wilkinson42 8 3 1Jouppila65 8 8 5McKay62 20 7 6Block66 21 11 11Ramin67 43 42 28Swisher68 18 18 18Chen43 8 8 5Legro69 9 9 5Cosenza31 9 9 9Lu19 12 12 12Robertson44 4 1 1

    Total 212 171 113

    603R.S. Date et al. Review of gallstone disease management

  • 7/24/2019 A Review of the Management of Gallstone Disease and Its

    6/10

    complicated and nonresolving biliary disease during preg-

    nancy. In our review, case studies reporting 5 LCs in

    pregnancy were excluded to minimize publication bias.

    Twenty reports were identified that included a total of

    197 patients (Table 6). Two patients requested termination

    of pregnancy at the time of surgery,46

    and there was onefetal death unrelated to surgery.47 No maternal deaths at-

    tributable to LC.

    Most investigators used the open technique for inser-

    tion of the first port. The Verres needle was used in the

    left upper quadrant by Upadhyay et al and by Geisler et

    al in 10 and 6 patients, respectively.33,48 Buser49 reported

    perforation of the uterus during the third trimester, which

    was caused by manipulation of a blunt 10-mm canula

    while attempting to insert a telescope. LC was completed,

    and the patient subsequently underwent uneventful Ce-

    sarean section.

    Open cholecystectomy versus LC. Four retrospective re-

    ports comparing open cholecystectomy (OC) versus LC

    were identified (Table 7). These studies did not show any

    significant difference in maternal and fetal outcome. There

    were 6 of 89 (6.74%) preterm deliveries in the LC group

    compared with 2 of 69 (2.90%) in the open-surgery group

    (P .27). One fetal death occurred in the LC group com-

    pared with 2 in the open-surgery group (P .41). The fetal

    death reported by Cosenza et al occurred on postsurgical

    day 6. This woman underwent LC converted to OC for

    gallstone-induced pancreatitis in the 14th week of gestation.In a report by Barone et al, a 27-year-old woman died from

    postsurgical hemorrhage after undergoing LC in the 20th

    week of gestation. The source of bleeding was not identi-

    fied. The other fetal death in this series occurred 4 weeks

    Table 5 GSP: conservative versus surgical treatment

    Cumulative data Conservative Operative P

    Patients (total n) 75 38Maternal mortality (n) 0 0Maternal morbidity (n) 1a 1b

    Preterm labor (n) 18 2 .01

    Fetal morbidity (n) 3

    c

    0Fetal mortality (n) 6 1 .28

    aSplenic hematoma.bprolonged total parenteral nutrition.clow birth weight.

    Table 6 LC case series

    Investigators Patients (n) IOC

    Time of surgery

    (trimester 1/2/3)

    Indication

    BC/AC/CC/GSP

    Mean surgical

    time (min)

    Abdominal

    pressure PTD

    Fetal

    mortality

    (trimester

    1/2/3)

    Maternal

    mortality (n)

    Morrell34 5 5 0/3/2 0/5/0/0 NA NA 0 0 0McKellar6 9 3 2/4/3 NA NA NA 0 0 0Soper70 5 0/5/0 5/0/0/0 51 12 0 0 0Elerding35 5 5 1/3/1 0/3/2/0 NA 15 0 0 0Lanzafame71 5 0/3/2 3/1/0/1 69 15 0 0 0Steinbrook72 10 3/6/1 0/8/2/0 NA 1215 0 0a 0Reyes-Tineo36 5 1 0/1/0/4 0 0 0Abuabara73 22 2/16/4 0/17/3//0b 59c 1014 1d 0 0Graham46 6 2/4/0 3/3/0/0 15 0 2e 0Geisler48 6 0/4/2 NA NA 15 0 0 0Gouldman74 8 1/7/0 0/2/4/2 59 12 0 0 0Muench75 16 3/11/2 7/3/0/6 67 1215 0 0 0Patel32 10 (2 open) 2 3/6/1 0/0/10/0 NA NA 0 0 0Buser49 10 2/4/4 0/10/0/0 NA NA 1 0 0

    Rizzo76 5 2/2/1 2/3/0/0 NA 10 0 0 0Rollins47 31 3/19/9 NA 61.2 13 2 1d 0Daradkeh77 20 4/11/5 0 0 0Halkic78 5 NA 0/5/0/0 75 NA 0 0 0Palanivelu79 9 0/9/0 0/8/0/0f 45.2 NA 0 0 0Upadhyay33 5 1 0/0/5 1/3/0/0g NA 12 0 0 0Total 195 17 28/117/42 21/72/21/13 60.8 1015 4 3 0

    PTD preterm delivery.aThree patients were lost to follow-up.btwo patients had choledocholithiasis.cincludes 2 transcystic CBD explorations.dunrelated to gallstones.evoluntary termination.fone patient had empyema.gone patient failed to gain weight.

    604 The American Journal of Surgery, Vol 196, No 4, October 2008

  • 7/24/2019 A Review of the Management of Gallstone Disease and Its

    7/10

    after surgery after the mother underwent OC in the 16th

    week of gestation.

    Laparoscopic surgery was compared with open surgery

    in pregnancy in 3 other studies. LC and OC formed the part

    of respective cohort, but they were not discussed separately

    in these articles.A large population study based on the Swedish Health

    Registry evaluated laparoscopic cases (including cholecys-

    tectomies) from 2 million deliveries in Sweden during a

    2-decade time frame (1973 to 1993).50 They compared 5

    fetal outcome parameters in pregnant patients undergoing

    laparotomy (n 2,491) with those in pregnant patients

    undergoing laparoscopy (n 2,233). They also compared

    the same outcome parameters in pregnant women undergo-

    ing surgery with the total population. There was no differ-

    ence in fetal outcome parameters between the laparoscopy

    and laparotomy groups in singleton pregnancies between 4

    and 20 weeks of gestation. The study suggested the follow-ing increased risks, relative to the total population, for

    infants in both the laparoscopy and laparotomy groups:

    weight 2,500 g, delivery at 37 weeks, and having in-

    creased incidence of growth restriction. It is not clear

    whether this increased risk is related to the disease process

    itself or to the surgery. The results of this large study are

    limited by the absence of disease-specific subgroup

    analysis.

    Two further case studies were reported by Amos et al

    (n 7 vs 5) and Conron et al (n 2 vs 9) comparing

    laparoscopic surgery (cholecystectomy, appendectomy, and

    diagnostic laparoscopy) with open surgery.51,52 Data onindividual sugeries are lacking in the report by Conron. In

    this study, laparoscopic surgery was performed earlier dur-

    ing pregnancy compared with open surgery (12 weeks vs 29

    weeks,P .001). There was 1 miscarriage 7 days after LC.

    The investigators concluded that laparoscopic surgery does

    not show higher fetal loss compared with open surgery.

    Contrary to this, Amos et al51 reported 4 fetal deaths oc-

    curring after laparoscopic surgery. Four patients in the lapa-

    roscopic group in this study were at increased risk of fetal

    loss from their diseases (three GSP and 1 perforated appen-

    dix). Three of these resulted in fetal death. It is difficult to

    say whether the fetal deaths were caused by the diseaseprocess or the surgery.

    Comments

    The spectrum of gallstone disease ranges from biliary

    colic to life-threatening pancreatitis; therefore, management

    must be tailored to the patient according to her presentation.

    The first available large study on pregnancy-related gallbladder disease was published in 1963, and in this series of

    17 patients, Greene et al53 noted fetal loss of 24% (4 of 17).

    Although a number of reports have been published since

    then, the dilemma still remains whether or not to treat these

    patients conservatively.

    Risks of conservative treatment of cholecystitis include

    risk to the fetus due to recurrent episodes, other complica-

    tions of gallstones, and risk of malnutrition caused by lack

    of oral intake. In contrast, surgical treatment carries risk to

    the fetus from surgery and anaesthesia and risks specific to

    laparoscopic surgery. In our review, it was evident that 27%

    of the patients failed to respond to conservative manage-

    ment. Although this group of patients should have been

    expected to have more severe disease than those who re-

    sponded to conservative management, there was no differ-

    ence in morbidity and mortality in the 2 groups.

    Surgical intervention, if necessary, is best deferred until

    the second trimester when fetal risk is at its lowest.54 The

    historic reasons for carrying out a surgery at this time

    include the fact that organogenesis is complete and the

    uterus is not big enough to obliterate the surgical view.

    However, equally good results have been noted during other

    trimesters as well.

    5559

    On the basis of 4 retrospective studies comparing LC

    with OC, it is difficult to recommend any particular treat-

    ment because these studies did not specifically look at the

    physiologic effects of pneumoperitoneum or CO2- induced

    acidosis on the fetus during LC or the effects of uterine

    manipulation during OC.31,40,55,60

    LC in pregnant women provides all of the advantages of

    laparoscopic surgerysuch as significantly reduced hospital-

    ization, decreased narcotic use, and quick return to a regular

    dietcompared with open laparotomy in pregnant women.40

    Other advantages of LC include less manipulation of the

    uterus and detection of other pathology that may bepresent.55 It also decreases the possibility of postoperative

    Table 7 LC versus OC

    Investigators

    LC OC

    Patients (n)

    EGA at

    surgery (wk) PTD

    Fetal

    death (n)

    Conversion from

    laparotomy (n)

    EGA at

    surgery (wk) PTD

    Fetal

    death (n)

    Curet40 12 28 0 0 10 28 0 0

    Barone60

    20 18.4 1 1 26 24.8 0 1Cosenza31 12 20.5 0 0 20 (2) 21 1 1Affleck55 45 21 6.9 5 0 13 (2) NA 1 0Total 89 6 1 69 2 2

    EGA estimated gestational age; NA not available; PTD preterm delivery.

    605R.S. Date et al. Review of gallstone disease management

  • 7/24/2019 A Review of the Management of Gallstone Disease and Its

    8/10

    deep vein thrombosis because improved early mobility can

    be promoted in such patients.

    Bile duct stones pose diagnostic as well as therapeutic

    dilemmas during pregnancy. Diagnostic modalities, such as

    ERCP and MRCP, are not without risk. The data showed

    that ERCP in pregnancy is reasonably safe if the radiation

    dose is kept to a minimum. The incidence of maternal

    pancreatitis and other complications occurring after ERCPis low. The literature also suggested that the procedure

    should only be performed by an experienced endoscopist,

    and the fetus should be shielded at all times.

    Even though there is paucity of data on the safety of

    MRCP, an inference can be extrapolated from the experi-

    ence of MRI during pregnancy. The American College of

    Radiologists guidelines recommend cautious use of MRI

    during pregnancy when the benefits outweigh the risks.61

    With the advent of ERCP and MRCP, the need for IOC

    is minimal, although specialized units use it routinely for

    demonstrating the anatomy of the biliary tree. There have

    been no reports investigating the safety of IOC during

    pregnancy. In the absence of clear evidence, potential risks

    should be discussed with the patient. Laparoscopic US scan

    appears to be an attractive alternative to IOC to detect

    retained CBD stones, but experience of this technique is

    limited to specialized units.18

    There have been few reported cases of CBD exploration

    during pregnancy. There was no significant morbidity or

    mortality during such, although there could have been pub-

    lication bias in reporting. It appears from the available

    literature that the management of CBD stones in pregnancy

    is similar to that in the nonpregnant population.Pancreatitis during pregnancy was thought to be idio-

    pathic in origin, and hyperlipidemia has been widely re-

    ported as a cause of AP.41 However, the advent of the US

    scanning has confirmed that the majority of cases are caused

    by gallstones.62

    The initial management of AP during pregnancy during

    pregnancy is similar to management in the general popula-

    tion. The subsequent management of severe AP is some-

    what less controversial because maternal safety is of para-

    mount importance, and fetal outcome becomes a secondary

    concern. However, controversy exists about the treatment of

    mild to moderate pancreatitis during pregnancy regardingearly elective cholecystectomy after index admission (Brit-

    ish Society of Gastroenterology guidelines).9 When chole-

    cystectomy is deferred until after delivery, nearly 60% of

    patients develop recurrence during the same pregnancy,

    which significantly increases morbidity, frequency, and

    length of hospitalization.20 There is also an increased risk of

    fetal loss, although this is not statistically significant. GSP

    also increases the risk of prematurity and babies born with

    low birth weight.

    To summarize:

    1. A quarter of pregnant patients with cholecystitis fail torespond to conservative treatment.

    2. The results of conservative and surgical management of

    cholecystitis are similar in terms of maternal and fetal

    morbidity and mortality.

    3. Although there is no difference between laparoscopic

    cholecystectomy and OC, LC might be the preferred

    option because of its inherent advantages.

    4. LC appears to be a safe procedure during all trimesters

    but is best carried out during the second trimester.5. It may be advisable for women with symptomatic gall-

    stones to undergo cholecystectomy before planning

    pregnancy.

    6. Although generally considered safe, there are no clear

    guidelines for the use of MRCP during pregnancy.

    7. ERCP is a safe intervention in patients with symptomatic

    choledocholithiasis if necessary precautions are taken.

    8. LC should be offered to the patients with mild to

    moderate GSP according to guidelines for nonpreg-

    nant patients.

    The following precautions should be exercised duringLC:

    1. Use open technique for insertion of the umbilical port.

    2. Avoid high intraperitoneal pressures.

    3. Use the left lateral position to minimize aortocaval com-

    pression.

    4. Avoid rapid changes in the position of the patient.

    5. Take care to use electrocautery cautiously and away

    from uterus.

    It must be realized that there are no randomised con-

    trolled trials to support the recommendations in this review.

    It is unlikely that such trials could be performed in the near

    future because of the ethical issues involved. It is also

    difficult to accumulate a sufficient number of cases from a

    single institution. Under the circumstances, the recommen-

    dations must be based on the currently available litera-

    ture, and their limitations should be appreciated. It is

    worth noting that overall morbidity and mortality is minimal

    in the published literature; however, this may be due to

    publication bias. We recommend the development of a

    central database at the regional or national level to improve

    the reporting of cases and to avoid publication bias.

    References

    1. Kammerer WS. Nonobstetric surgery during pregnancy. Med Clin

    North Am 1979;63:115764.

    2. Daradkeh S, Sumrein I, Daoud F, et al. Management of gallbladder

    stones during pregnancy: conservative treatment or laparoscopic cho-

    lecystectomy? Hepatogastroenterology 1999;46:30746.

    3. Gurbuz AT, Peetz ME. The acute abdomen in the pregnant patient. Is

    there a role for laparoscopy? Surg Endosc 1997;11:98102.

    4. Jamal A, Gorski TF, Nguyen HQ, et al. Laparoscopic cholecystectomy

    during pregnancy. Surg Rounds 1997;20:40815.

    5. Ko CW. Risk factors for gallstone-related hospitalization during preg-

    nancy and the postpartum. Am J Gastroenterol 2006;101:22638.

    606 The American Journal of Surgery, Vol 196, No 4, October 2008

  • 7/24/2019 A Review of the Management of Gallstone Disease and Its

    9/10

    6. McKellar DP, Anderson CT, Boynton CJ, et al. Cholecystectomy

    during pregnancy without fetal loss. Surg Gynecol Obstet 1992;174:

    4658.

    7. Lau H, Lo CY, Patil NG, et al. Early versus delayed-interval laparo-

    scopic cholecystectomy for acute cholecystitis: a metaanalysis. Surg

    Endosc 2006;20:827.

    8. Weigand K, Koninger J, Encke J, et al. Acute cholecystitisearly

    laparoscopic surgery versus antibiotic therapy and delayed elective

    cholecystectomy: ACDC-study. Trials 2007;8:29.

    9. UK guidelines for the management of acute pancreatitis. Gut 2005;

    54(suppl. 3):iii1iii9.

    10. Nezhat FR, Tazuke S, Nezhat CH, et al. Laparoscopy during preg-

    nancy: a literature review. JSLS 1997;1:1727.

    11. Sungler P, Heinerman PM, Steiner H, et al. Laparoscopic cholecys-

    tectomy and interventional endoscopy for gallstone complications dur-

    ing pregnancy. Surg Endosc 2000;14:26771.

    12. Bagci S, Tuzun A, Erdil A, et al. Treatment of choledocholithiasis in

    pregnancy: a case report. Arch Gynecol Obstet 2003;267:23941.

    13. Tuech JJ, Binelli C, Aube C, et al. Management of choledocholithiasis

    during pregnancy by magnetic resonance cholangiography and lapa-

    roscopic common bile duct stone extraction. Surg Laparosc Endosc

    Percutan Tech 2000;10:3235.

    14. Dixon NP, Faddis DM, Silberman H. Aggressive management of

    cholecystitis during pregnancy. Am J Surg 1987;154:2924.15. Hiatt JR, Hiatt JC, Williams RA, et al. Biliary disease in pregnancy:

    strategy for surgical management. Am J Surg 1986;151:2635.

    16. Landers D, Carmona R, Crombleholme W, et al. Acute cholecystitis in

    pregnancy. Obstet Gynecol 1987;69:1313.

    17. Elamin AM, Yahia Al-Shehri M, Abu-Eshy S, et al. Is surgical inter-

    vention in acute cholecystitis in pregnancy justified? J Obstet Gynae-

    col 1997;17:4358.

    18. Glasgow RE, Visser BC, Harris HW, et al. Changing management of

    gallstone disease during pregnancy. Surg Endosc 1998;12:2416.

    19. Lu EJ, Curet MJ, El-Sayed YY, et al. Medical versus surgical man-

    agement of biliary tract disease in pregnancy. Am J Surg 2004;188:

    7559.

    20. Swisher SG, Schmit PJ, Hunt KK, et al. Biliary disease during preg-

    nancy. Am J Surg 1994;168:576581.21. Farca A, Aguilar ME, Rodriguez G, et al. Biliary stents as temporary

    treatment for choledocholithiasis in pregnant patients. Gastrointest

    Endosc 1997;46:99101.

    22. Kahaleh M, Hartwell GD, Arseneau KO, et al. Safety and efficacy of

    ERCP in pregnancy. Gastrointest Endosc 2004;60:28792.

    23. Tham TC, Vandervoort J, Wong RC, et al. Safety of ERCP during

    pregnancy. Am J Gastroenterol 2003;98:30811.

    24. Uomo G, Manes G, Picciotto FP, et al. Endoscopic treatment of acute

    biliary pancreatitis in pregnancy. J Clin Gastroenterol 1994;18:2502.

    25. Simmons DC, Tarnasky PR, Rivera-Alsina ME, et al. Endoscopic

    retrograde cholangiopancreatography (ERCP) in pregnancy without

    the use of radiation. Am J Obstet Gynecol 2004;190:14679.

    26. Barthel JS, Chowdhury T, Miedema BW. Endoscopic sphincterotomy

    for the treatment of gallstone pancreatitis during pregnancy. SurgEndosc 1998;12:3949.

    27. Gupta R, Tandan M, Lakhtakia S, et al. Safety of therapeutic ERCP in

    pregnancyan Indian experience. Indian J Gastroenterol 2005;24:1613.

    28. Jamidar PA, Beck GJ, Hoffman BJ, et al. Endoscopic retrograde

    cholangiopancreatography in pregnancy. Am J Gastroenterol 1995;90:

    12637.

    29. Haddad O, Porcu-Buisson G, Sakr R, et al. Diagnosis and management

    of adenocarcinoma of the ampulla of Vater during pregnancy. Eur J

    Obstet Gynecol Reprod Biol 2005;119:2469.

    30. Jabbour N, Brenner M, Gagandeep S, Lin A, et al. Major hepatobiliary

    surgery during pregnancy: safety and timing. Am Surg 2005;71:3548.

    31. Cosenza CA, Saffari B, Jabbour N, et al. Surgical management of

    biliary gallstone disease during pregnancy. Am J Surg 1999;178:

    5458.

    32. Patel SG, Veverka TJ. Laparoscopic cholecystectomy in pregnancy.

    Curr Surg 2002;59:74 8.

    33. Upadhyay A, Stanten S, Kazantsev G, et al. Laparoscopic management

    of a nonobstetric emergency in the third trimester of pregnancy. Surg

    Endosc 2007;21:13448.

    34. Morrell DG, Mullins JR, Harrison PB. Laparoscopic cholecystectomy

    during pregnancy in symptomatic patients. Surgery 1992;112:8569.

    35. Elerding SC. Laparoscopic cholecystectomy in pregnancy. Am J Surg

    1993;165:6257.

    36. Reyes-Tineo R. Laparoscopic cholecystectomy in pregnancy. Bol

    Asoc Med P R 1997;89:911.

    37. DePaula AL, Hashiba K, Bafutto M. Laparoscopic management of

    choledocholithiasis. Surg Endosc 1994;8:1399403.

    38. Kim YW, Zagorski SM, Chung MH. Laparoscopic common bile duct

    exploration in pregnancy with acute gallstone pancreatitis. JSLS 2006;

    10:7882.

    39. Liberman MA, Phillips EH, Carroll B, et al. Management of chole-

    docholithiasis during pregnancy: a new protocol in the laparoscopic

    era. J Laparoendosc Surg 1995;5:399403.

    40. Curet MJ, Allen D, Josloff RK, et al. Laparoscopy during pregnancy.

    Arch Surg 1996;131:546551.

    41. Langmade CF, Edmondson HA. Acute pancreatitis during pregnancy

    and the postpartum period: a report of nine cases. Surg Gynecol Obstet

    1951;92:4352.

    42. Wilkinson EJ. Acute pancreatitis in pregnancy: a review of 98 cases

    and a report of 8 new cases. Obstet Gynecol Surv 1973;28:281303.43. Chen CP, Wang KG, Su TH, et al. Acute pancreatitis in pregnancy.

    Acta Obstet Gynecol Scand 1995;74:60710.

    44. Robertson KW, Stewart IS, Imrie CW. Severe acute pancreatitis and

    pregnancy. Pancreatology 2006;6:30915.

    45. Ghumman E, Barry M, Grace PA. Management of gallstones in preg-

    nancy. Br J Surg 1997;84:164650.

    46. Graham G, Baxi L, Tharakan T. Laparoscopic cholecystectomy during

    pregnancy: a case series and review of the literature. Obstet Gynecol

    Surv 1998;53:56674.

    47. Rollins MD, Chan KJ, Price RR. Laparoscopy for appendicitis and

    cholelithiasis during pregnancy: a new standard of care. Surg Endosc

    2004;18:23741.

    48. Geisler JP, Rose SL, Mernitz CS, et al. Non-gynecologic laparoscopy

    in second and third trimester pregnancy: obstetric implications. JSLS1998;2:2358.

    49. Buser KB. Laparoscopic surgery in the pregnant patientone sur-

    geons experience in a small rural hospital. JSLS 2002;6:1214.

    50. Reedy MB, Kallen B, Kuehl TJ. Laparoscopy during pregnancy: a

    study of five fetal outcome parameters with use of the Swedish Health

    Registry. Am J Obstet Gynecol 1997;177:6739.

    51. Amos JD, Schorr SJ, Norman PF, et al. Laparoscopic surgery during

    pregnancy. Am J Surg 1996;171:4357.

    52. Conron RW Jr, Abbruzzi K, Cochrane SO, et al. Laparoscopic proce-

    dures in pregnancy. Am Surg 1999;65:25963.

    53. Greene J, Rogers A, Rubin L. Fetal loss after cholecystectomy during

    pregnancy. Can Med Assoc J 1963;88:5767.

    54. Guidelines for Laparoscopic Surgery During Pregnancy. Los Angeles,

    CA: Society of American Gastrointestinal Endoscopic Surgeons.55. Affleck DG, Handrahan DL, Egger MJ, et al. The laparoscopic man-

    agement of appendicitis and cholelithiasis during pregnancy. Am J

    Surg 1999;178:5239.

    56. Eichenberg BJ, Vanderlinden J, Miguel C, et al. Laparoscopic chole-

    cystectomy in the third trimester of pregnancy. Am Surg 1996;62:

    8747.

    57. Coelho JC, Vianna RM, da Costa MA, et al. Laparoscopic cholecys-

    tectomy in the third trimester of pregnancy. Arq Gastroenterol 1999;

    36:903.

    58. Sen G, Nagabhushan JS, Joypaul V. Laparoscopic cholecystectomy in

    the third trimester of pregnancy. J Obstet Gynaecol 2002;22:5567.

    59. Pucci RO, Seed RW. Case report of laparoscopic cholecystectomy in

    the third trimester of pregnancy. Am J Obstet Gynecol 1991;165:

    4012.

    60. Barone JE, Bears S, Chen S, et al. Outcome study of cholecystectomy

    during pregnancy. Am J Surg 1999;177:2326.

    607R.S. Date et al. Review of gallstone disease management

  • 7/24/2019 A Review of the Management of Gallstone Disease and Its

    10/10

    61. Kanal E, Barkovich AJ, Bell C, et al. ACR guidance document for safe

    MR practices: 2007. AJR Am J Roentgenol 2007;188:144774.

    62. McKay AJ, ONeill J, Imrie CW. Pancreatitis, pregnancy and gall-

    stones. Br J Obstet Gynaecol 1980;87:4750.

    63. Howden JK, Baillie J. Preoperative versus postoperative endoscopic

    retrograde cholangiopancreatography in mild to moderate pancreatitis:

    a prospective randomized trial. Gastrointest Endosc 2001;53:8346.

    64. Corlett RC Jr, Mishell DR Jr. Pancreatitis in pregnancy. Am J Obstet

    Gynecol 1972;113:28190.65. Jouppila P, Mokka R, Larmi TK. Acute pancreatitis in pregnancy. Surg

    Gynecol Obstet 1974;139:87982.

    66. Block P, Kelly TR. Management of gallstone pancreatitis during preg-

    nancy and the postpartum period. Surg Gynecol Obstet 1989;168:

    4268.

    67. Ramin KD, Ramin SM, Richey SD, et al. Acute pancreatitis in preg-

    nancy. Am J Obstet Gynecol 1995;173:18791.

    68. Swisher SG, Hunt KK, Schmit PJ, et al. Management of pancreatitis

    complicating pregnancy. Am Surg 1994;60:75962.

    69. Legro RS, Laifer SA. First-trimester pancreatitis. Maternal and neo-

    natal outcome. J Reprod Med 1995;40:68995.

    70. Soper NJ, Hunter JG, Petrie RH. Laparoscopic cholecystectomy dur-

    ing pregnancy. Surg Endosc 1992;6:1157.

    71. Lanzafame RJ. Laparoscopic cholecystectomy during pregnancy. Sur-

    gery 1995;118:62733.

    72. Steinbrook RA, Brooks DC, Datta S. Laparoscopic cholecystectomy

    during pregnancy. Review of anesthetic management, surgical consid-

    erations. Surg Endosc 1996;10:5115.

    73. Abuabara SF, Gross GW, Sirinek KR. Laparoscopic cholecystectomy

    during pregnancy is safe for both mother and fetus. J Gastrointest Surg

    1997;1:4852.

    74. Gouldman JW, Sticca RP, Rippon MB, et al. Laparoscopic cholecys-

    tectomy in pregnancy. Am Surg 1998;64:938.

    75. Muench J, Albrink M, Serafini F, et al. Delay in treatment of biliary

    disease during pregnancy increases morbidity and can be avoided with

    safe laparoscopic cholecystectomy. Am Surg 2001;67:53943.

    76. Rizzo AG. Laparoscopic surgery in pregnancy: long-term follow-up.

    J Laparoendosc Adv Surg Tech A 2003;13:115.

    77. Daradkeh S. Laparoscopic cholecystectomy: analytical study of 1208

    cases. Hepatogastroenterology 2005;52:10114.

    78. Halkic N, Tempia-Caliera AA, Ksontini R, et al. Laparoscopic man-

    agement of appendicitis and symptomatic cholelithiasis during preg-

    nancy. Langenbecks Arch Surg 2006;391:46771.

    79. Palanivelu C, Rangarajan M, Senthilkumaran S, et al. Safety and

    efficacy of laparoscopic surgery in pregnancy: experience of a single

    institution. J Laparoendosc Adv Surg Tech A 2007;17:18690.

    608 The American Journal of Surgery, Vol 196, No 4, October 2008